Deborah Miller

General Counsel at NUVALENT, INC.

Net worth: 3 M $ as of 30/06/2024

48 year

66 connections

Consumer Services

Health Technology

Commercial Services

Active connections

Name	Gender	Age	Linked companies	Collaboration
James Porter	M	48	NUVALENT, INC. INFINITY PHARMACEUTICALS, INC.	22 years
Joseph Pearlberg	M	60	NUVALENT, INC. INFINITY PHARMACEUTICALS, INC.	7 years
Benjamin Lane	M	-	NUVALENT, INC.	4 years
Cameron Wheeler	M	45	NUVALENT, INC.	7 years
Norman Selby	M	71	INFINITY PHARMACEUTICALS, INC.	12 years
Philip Engel	M	-	NUVALENT, INC.	1 years
Alexandra Balcom	F	40	NUVALENT, INC.	3 years
Matthew Shair	M	55	NUVALENT, INC.	7 years
Darlene Noci	F	47	NUVALENT, INC.	3 years
Sapna R. Srivastava	M	53	NUVALENT, INC.	3 years
Emily Conley	M	42	NUVALENT, INC.	2 years
D. Gilliland	M	69	NUVALENT, INC.	3 years
Michael Meyers	M	74	NUVALENT, INC.	2 years
Andrew Hack	M	50	NUVALENT, INC.	3 years
Anna Protopapas	F	59	NUVALENT, INC.	2 years
Christopher Turner	M	56	NUVALENT, INC.	3 years
Matthew Metivier	M	-	NUVALENT, INC.	2 years
Yoshiharu Ikeda	M	-	Sumitomo Pharma America, Inc. Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 1984 and is headquartered in Marlborough, MA.	4 years
Ruth Adams	F	-	NUVALENT, INC.	4 years
Jessie Lin	F	-	NUVALENT, INC.	3 years
Viola Zhu	M	-	NUVALENT, INC.	-
Jeffrey Lee	M	-	NUVALENT, INC.	2 years
Virginia Vetter	F	-	NUVALENT, INC.	-

Connections Chart

Multi-company connection

Former connections

Name	Gender	Age	Linked companies	Collaboration
Lawrence Bloch	M	58	INFINITY PHARMACEUTICALS, INC.	11 years
Nobuhiko Tamura	M	68	Sumitomo Pharma America, Inc. Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 1984 and is headquartered in Marlborough, MA.	5 years
Christopher M. Lindblom	M	52	INFINITY PHARMACEUTICALS, INC.	8 years
Gerald Quirk	M	56	INFINITY PHARMACEUTICALS, INC.	6 years
Thomas Lynch	M	63	INFINITY PHARMACEUTICALS, INC.	5 years
Vito Palombella	M	61	INFINITY PHARMACEUTICALS, INC.	12 years
Jeffrey Berkowitz	M	58	INFINITY PHARMACEUTICALS, INC.	6 years
Gwen A. Fyfe	M	72	INFINITY PHARMACEUTICALS, INC.	4 years
Patrick Lee	M	67	INFINITY PHARMACEUTICALS, INC.	7 years
José Baselga	M	65	INFINITY PHARMACEUTICALS, INC.	3 years
Jaren Madden	F	-	INFINITY PHARMACEUTICALS, INC.	7 years
Martin Babler	M	59	INFINITY PHARMACEUTICALS, INC.	6 years
Dave Grayzel	M	56	INFINITY PHARMACEUTICALS, INC.	8 years
Bob Jackson	M	-	NUVALENT, INC.	5 years
Steven Holtzman	M	70	INFINITY PHARMACEUTICALS, INC.	17 years
Eric S. Lander	M	67	INFINITY PHARMACEUTICALS, INC.	10 years
Franklin H. Moss	M	75	INFINITY PHARMACEUTICALS, INC.	10 years
Jayne Kauffman	F	-	INFINITY PHARMACEUTICALS, INC.	-
Patrick F. Kelly	M	60	INFINITY PHARMACEUTICALS, INC.	3 years
Ronald Vigliotta	M	51	INFINITY PHARMACEUTICALS, INC.	7 years
Scott Barrett	M	61	INFINITY PHARMACEUTICALS, INC.	2 years
David Frawley	M	-	Sumitomo Pharma America, Inc. Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 1984 and is headquartered in Marlborough, MA.	-
Michael Ferraresso	M	-	INFINITY PHARMACEUTICALS, INC.	4 years
Michael Landsittel	M	52	INFINITY PHARMACEUTICALS, INC.	-
David Roth	M	61	INFINITY PHARMACEUTICALS, INC.	2 years
John Lee	M	56	INFINITY PHARMACEUTICALS, INC.	15 years
Steve Fedan	M	-	NUVALENT, INC.	-
Vincent Kosewski	M	-	Sumitomo Pharma America, Inc. Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 1984 and is headquartered in Marlborough, MA.	10 years
James Tananbaum	M	60	INFINITY PHARMACEUTICALS, INC.	6 years
Colleen Wilson	F	47	INFINITY PHARMACEUTICALS, INC.	2 years
Elizabeth G. Trehu	M	64	INFINITY PHARMACEUTICALS, INC.	2 years
Winston K. C. Lam	M	-	INFINITY PHARMACEUTICALS, INC.	-
Tamyra A. Toole	F	-	INFINITY PHARMACEUTICALS, INC.	9 years
Winselow Tucker	M	56	INFINITY PHARMACEUTICALS, INC.	-
William Bertrand	M	59	INFINITY PHARMACEUTICALS, INC.	1 years
Jeanette W. Kohlbrenner	F	-	INFINITY PHARMACEUTICALS, INC.	10 years
Joshua D. Hamermesh	M	51	INFINITY PHARMACEUTICALS, INC.	3 years
Julian Adams	M	69	INFINITY PHARMACEUTICALS, INC.	11 years
Harry Hixson	M	84	INFINITY PHARMACEUTICALS, INC.	9 years
Pedro D. Santabarbara	M	71	INFINITY PHARMACEUTICALS, INC.	4 years
Arnold Levine	M	84	INFINITY PHARMACEUTICALS, INC.	6 years
Sujay Kango	M	60	INFINITY PHARMACEUTICALS, INC.	2 years
Matthew D’Ambrosio	M	55	Sumitomo Pharma America, Inc. Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 1984 and is headquartered in Marlborough, MA.	7 years

Statistics

Country	Connections	% of total
United States	66	100.00%

Age of Connections

Active

Past

Male

Female

Members of the board

Executives

Origin of connections